1. Home
  2. ASMB vs SHMD Comparison

ASMB vs SHMD Comparison

Compare ASMB & SHMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Assembly Biosciences Inc.

ASMB

Assembly Biosciences Inc.

N/A

Current Price

$21.21

Market Cap

512.1M

Sector

Health Care

ML Signal

N/A

Logo SCHMID Group N.V. Class A Ordinary Shares

SHMD

SCHMID Group N.V. Class A Ordinary Shares

N/A

Current Price

$2.51

Market Cap

198.2M

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
ASMB
SHMD
Founded
2005
1864
Country
United States
Germany
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
512.1M
198.2M
IPO Year
2010
2023

Fundamental Metrics

Financial Performance
Metric
ASMB
SHMD
Price
$21.21
$2.51
Analyst Decision
Strong Buy
Analyst Count
5
0
Target Price
★ $51.20
N/A
AVG Volume (30 Days)
203.5K
★ 779.1K
Earning Date
11-24-2026
11-25-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 91.78
N/A
EPS
N/A
★ N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$49.82
Revenue Next Year
N/A
$48.26
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$19.20
$2.09
52 Week High
$39.71
$10.65

Technical Indicators

Market Signals
Indicator
ASMB
SHMD
Relative Strength Index (RSI) 48.54 39.73
Support Level $19.30 N/A
Resistance Level $21.65 $3.65
Average True Range (ATR) 1.01 0.25
MACD 0.40 -0.02
Stochastic Oscillator 78.82 38.73

Price Performance

Historical Comparison
ASMB
SHMD

About ASMB Assembly Biosciences Inc.

Assembly Biosciences Inc is a clinical-stage biotechnology company. The Company's pipeline includes multiple clinical-stage investigational therapies, including: (1) two long-acting helicase-primase inhibitors (HPI) for the treatment of recurrent genital herpes; (2) an orally bioavailable hepatitis delta virus entry inhibitor; and (3) a potent next-generation capsid assembly modulator designed to disrupt the replication cycle of hepatitis B virus (HBV) at several key points. The Company's pipeline also includes a novel, oral broad-spectrum non-nucleoside polymerase inhibitor (NNPI) for the treatment of transplant-related herpesviruses.

About SHMD SCHMID Group N.V. Class A Ordinary Shares

Schmid Group NV is a supplier of equipment, software and services for various industries such as printed circuit board (PCB), substrate manufacturing, photovoltaics, and glass and energy storage with a focus on the highest end of this market in terms of technology and performance. It focuses on a modular product portfolio of machinery to use in the manufacturing of high-end PCB equipment and semiconductor packaging devices which includes common flexible circuit fabrication techniques such as subtractive, semi-additive processes (SAP) and modified semi-additive processes (mSAP).

Share on Social Networks: